Go to website
News of the Week

[May 19, 2022] News of the Week

Rare disease pharmaceutical industry trendsRocket Pharmaceuticals, Inc. announced the progress of phase 2 clinical trials for Fanconi Anemia treatment and Phase 1 clinical trials for Danaon…

Newsroom

3billion was selected as a business operator for the national project

3billion plans to form a consortium with Seoul National University Hospital and Kakao Healthcare to develop an AI integrated software solution for multifaceted analysis of rare…

Rethinking Clinical Practice for Rare Neurodevelopmental Disorders in the Genomic Era

Webinar at the 10th Alexandria Pediatric Neurology Conference Speaker: Dr. Hane Lee, Chief Genomics Officer (CGO) of 3billion 3billion's Chief Genomics Officer, Dr. Hane Lee, presented…

My Odyssey

My Odyssey #14: Siblings diagnosed with Pyridoxine-dependent Epilepsy

Genetic testing, providing answers for two daughters It was a typical day in the summer. I (Anum Shafique) went to locate families with epileptic disorders in…

Insights

Orphan drug discovery using genomic data and artificial intelligence

According to the statistics, orphan drugs accounted for 58% of the newly approved drugs in 2020 and the total sale of orphan drugs accounted for approximately…

News of the Week

[May 12, 2022] News of the Week

Rare disease pharmaceutical industry trendsThe US Food and Drug Administration's Center for Drug Evaluation and Research (CDER) has announced the Accelerating Rare Disease Cures (ARC) program…

News of the Week

[May 6, 2022] News of the Week

Rare disease pharmaceutical industry trendsThe FDA approved the first treatment for penicillamine-tolerant patients with Wilson's disease. Wilson's disease is a rare genetic disorder in which copper…

Newsroom

3billion Company Video: From 3 billion bases to 1 answer

3billion released a company video explaining why rare disease is so difficult to diagnose and how 3billion is solving them. Check out the video and learn…

Insights

How can you diagnose mitochondrial disease using WES and WGS?

What is mitochondrial disease? Mitochondria is a small worm-like organelle that performs cellular respiration called oxidative phosphorylation. Oxidative phosphorylation is a complex biochemical pathway that produces…

News of the Week

[April 28, 2022] News of the Week

Rare disease pharmaceutical industry trendsThe Czech health minister has urged the EU to jointly purchase medicines for rare diseases to lower the price of drugs and…

Newsroom

3billion aims to lead genetic diagnosis in global market

Let’s take a look at the interview article with ‘Korea Biomedical Review’ of 3billion’s CEO Changwon Keum. There are many difficulties in diagnosing rare…

News of the Week

[April 21, 2022] News of the Week

Rare disease pharmaceutical industry trendsU.S FDA designated Aytu BioPharma’s Vascular Ehlers Danlos Syndrome treatment ‘AR101’ as a fast track. The treatment had already been…

Subscribe to our newletter

Get email updates on 3billion's announcements & updates, clinical cases, and rare disease information

Thank you for
subscribing 👏